Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Jin Xinong: The company currently has no fresh food business.
06/08/2025
Jin Xinong stated on the interactive platform on August 6 that the company currently has no fresh food business.
Latest
2 m ago
The China Photovoltaic Industry Association announced that the National Development and Reform Commission and the State Administration for Market Regulation have conducted research and drafted the Amendments to the Price Law, and recently opened it for public comments. In order to fully reflect the demands of the photovoltaic industry enterprises, the China Photovoltaic Industry Association is now seeking opinions and suggestions from various units on the Amendments to the Price Law. All relevant units are requested to provide opinions, suggestions, and reasons for modifications to the draft focusing on aspects such as pricing behavior norms, price control mechanisms, price supervision and inspection, legal responsibilities, and other related issues based on the actual situation of the photovoltaic industry.
2 m ago
Capital Online: Sign the four-party regulatory agreement for fundraising.
2 m ago
Transparent Life (300642.SZ), a subsidiary of Transparent Life in Jiangxi, has obtained two medical device registration certificates.
3 m ago
China Biopharmaceuticals (01177) independently developed the drug Ruxolitinib tablets "TQ05105 (JAK/ROCK inhibitor)", which has been included in the breakthrough therapy program.
3 m ago
KeLan Software: Part of the shares held by the controlling shareholder and actual controller acting in concert have been judicially transferred.
See all latest